title: Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.
abstract: OBJECTIVE
  It is unknown whether prolonged childhood exposure to stimulant medication for the treatment of attention deficit hyperactivity disorder (ADHD) increases the risk for developing abnormalities in blood pressure or heart rate. The authors examined the association between stimulant medication and blood pressure and heart rate over 10 years.
  
  
  METHODS
  A total of 579 children, ages 7–9, were randomly assigned to 14 months of medication treatment, behavioral therapy, the combination of the two, or usual community treatment. The controlled trial was followed by naturalistic treatment with periodic assessments. Blood pressure and heart rate data were first analyzed with linear regression models based on an intent-to-treat approach, using raw data and the blood pressure categories of prehypertension and hypertension. Currently medicated patients were then compared with never or previously medicated patients. Associations between cumulative stimulant exposure and blood pressure or heart rate were assessed.
  
  
  RESULTS
  No treatment effect on either systolic or diastolic blood pressure could be detected. Children who were treated with stimulants had a higher heart rate (mean=84.2 bpm [SD=12.4] on medication alone and mean=84.6 bpm [SD=12.2] on medication plus behavioral therapy) than those who were treated with behavioral therapy alone (mean=79.1 bpm [SD=12.0]) or those who received usual community treatment (mean=78.9 bpm [SD=12.9]) at the end of the 14-month controlled trial, but not thereafter. Stimulant medication did not increase the risk for tachycardia, but greater cumulative stimulant exposure was associated with a higher heart rate at years 3 and 8.
  
  
  CONCLUSIONS
  Stimulant treatment did not increase the risk for prehypertension or hypertension over the 10-year period of observation. However, stimulants had a persistent adrenergic effect on heart rate during treatment.
authors: NIMH, Bethesda, MD, USA. bvitiell@mail.nih.gov
authors: Benedetto
authors: B
authors: Vitiello
authors: Glen R
authors: GR
authors: Elliott
authors: James M
authors: JM
authors: Swanson
authors: L Eugene
authors: LE
authors: Arnold
authors: Lily
authors: L
authors: Hechtman
authors: Howard
authors: H
authors: Abikoff
authors: Brooke S G
authors: BS
authors: Molina
authors: Karen
authors: K
authors: Wells
authors: Timothy
authors: T
authors: Wigal
authors: Peter S
authors: PS
authors: Jensen
authors: Laurence L
authors: LL
authors: Greenhill
authors: Jonathan R
authors: JR
authors: Kaltman
authors: Joanne B
authors: JB
authors: Severe
authors: Carol
authors: C
authors: Odbert
authors: Kwan
authors: K
authors: Hur
authors: Robert
authors: R
authors: Gibbons
mesh_terms: D018663:Adrenergic Agents; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001521:Behavior Therapy / Q000379:methods; D001794:Blood Pressure / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000379:methods; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D010043:Outcome and Process Assessment, Health Care; D060735:Pharmacovigilance; D012307:Risk Factors; D013610:Tachycardia / Q000139:chemically induced*; D013997:Time Factors
chemical_list: D018663:Adrenergic Agents; D000697:Central Nervous System Stimulants